Covid-19 Impact on Insomnia Medication Market , Global Research Reports 2020-2021

1.2 Market Segmentation

1.3 Research Objectives

1.4 Research Methodology

1.4.1 Research Process

1.4.2 Data Triangulation

1.4.3 Research Approach

1.4.4 Base Year

1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth

1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections

1.5.2 Covid-19 Impact: Commodity Prices Indices

1.5.3 Covid-19 Impact: Global Major Government Policy

1.6 The Covid-19 Impact on Insomnia Medication Industry

1.7 COVID-19 Impact: Insomnia Medication Market Trends

2 Global Insomnia Medication Quarterly Market Size Analysis

2.1 Insomnia Medication Business Impact Assessment - COVID-19

2.1.1 Global Insomnia Medication Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026

2.1.2 Global Insomnia Medication Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026

2.2 Global Insomnia Medication Quarterly Market Size 2020-2021

2.3 COVID-19-Driven Market Dynamics and Factor Analysis

2.3.1 Drivers

2.3.2 Restraints

2.3.3 Opportunities

2.3.4 Challenges

3 Quarterly Competitive Assessment, 2020

3.1 Global Insomnia Medication Quarterly Market Size by Manufacturers, 2019 VS 2020

3.2 Global Insomnia Medication Factory Price by Manufacturers

3.3 Location of Key Manufacturers Insomnia Medication Manufacturing Factories and Area Served

3.4 Date of Key Manufacturers Enter into Insomnia Medication Market

3.5 Key Manufacturers Insomnia Medication Product Offered

3.6 Mergers & Acquisitions, Expansion Plans

4 Impact of Covid-19 on Insomnia Medication Segments, By Type

4.1 Introduction

1.4.1 Nonbenzodiazepine Receptor Agonists

1.4.2 Benzodiazepine Receptor Agonists

1.4.3 The Selective Melatonin Receptor Agonist Ramelteon

1.4.4 Sedating Antidepressants

4.2 By Type, Global Insomnia Medication Market Size, 2019-2021

4.2.1 By Type, Global Insomnia Medication Market Size by Type, 2020-2021

4.2.2 By Type, Global Insomnia Medication Price, 2020-2021

5 Impact of Covid-19 on Insomnia Medication Segments, By Application

5.1 Overview

5.5.1 Adults

5.5.2 Kids

5.2 By Application, Global Insomnia Medication Market Size, 2019-2021

5.2.1 By Application, Global Insomnia Medication Market Size by Application, 2019-2021

5.2.2 By Application, Global Insomnia Medication Price, 2020-2021

6 Geographic Analysis

6.1 Introduction

6.2 North America

6.2.1 Macroeconomic Indicators of US

6.2.2 US

6.2.3 Canada

6.3 Europe

6.3.1 Macroeconomic Indicators of Europe

6.3.2 Germany

6.3.3 France

6.3.4 UK

6.3.5 Italy

6.4 Asia-Pacific

6.4.1 Macroeconomic Indicators of Asia-Pacific

6.4.2 China

6.4.3 Japan

6.4.4 South Korea

6.4.5 India

6.4.6 ASEAN

6.5 Rest of World

6.5.1 Latin America

6.5.2 Middle East and Africa

7 Company Profiles

7.1 Eisai

7.1.1 Eisai Business Overview

7.1.2 Eisai Insomnia Medication Quarterly Production and Revenue, 2020

7.1.3 Eisai Insomnia Medication Product Introduction

7.1.4 Eisai Response to COVID-19 and Related Developments

7.2 Merck

7.2.1 Merck Business Overview

7.2.2 Merck Insomnia Medication Quarterly Production and Revenue, 2020

7.2.3 Merck Insomnia Medication Product Introduction

7.2.4 Merck Response to COVID-19 and Related Developments

7.3 Pfizer

7.3.1 Pfizer Business Overview

7.3.2 Pfizer Insomnia Medication Quarterly Production and Revenue, 2020

7.3.3 Pfizer Insomnia Medication Product Introduction

7.3.4 Pfizer Response to COVID-19 and Related Developments

7.4 Sanofi

7.4.1 Sanofi Business Overview

7.4.2 Sanofi Insomnia Medication Quarterly Production and Revenue, 2020

7.4.3 Sanofi Insomnia Medication Product Introduction

7.4.4 Sanofi Response to COVID-19 and Related Developments

7.5 Takeda

7.5.1 Takeda Business Overview

7.5.2 Takeda Insomnia Medication Quarterly Production and Revenue, 2020

7.5.3 Takeda Insomnia Medication Product Introduction

7.5.4 Takeda Response to COVID-19 and Related Developments

7.6 Vanda Pharmaceuticals

7.6.1 Vanda Pharmaceuticals Business Overview

7.6.2 Vanda Pharmaceuticals Insomnia Medication Quarterly Production and Revenue, 2020

7.6.3 Vanda Pharmaceuticals Insomnia Medication Product Introduction

7.6.4 Vanda Pharmaceuticals Response to COVID-19 and Related Developments

7.7 Astellas

7.7.1 Astellas Business Overview

7.7.2 Astellas Insomnia Medication Quarterly Production and Revenue, 2020

7.7.3 Astellas Insomnia Medication Product Introduction

7.7.4 Astellas Response to COVID-19 and Related Developments

7.8 Dainippon Sumitomo

7.8.1 Dainippon Sumitomo Business Overview

7.8.2 Dainippon Sumitomo Insomnia Medication Quarterly Production and Revenue, 2020

7.8.3 Dainippon Sumitomo Insomnia Medication Product Introduction

7.8.4 Dainippon Sumitomo Response to COVID-19 and Related Developments

7.9 ECR Pharmaceuticals (Valeant)

7.9.1 ECR Pharmaceuticals (Valeant) Business Overview

7.9.2 ECR Pharmaceuticals (Valeant) Insomnia Medication Quarterly Production and Revenue, 2020

7.9.3 ECR Pharmaceuticals (Valeant) Insomnia Medication Product Introduction

7.9.4 ECR Pharmaceuticals (Valeant) Response to COVID-19 and Related Developments

7.10 Flynn Pharma

7.10.1 Flynn Pharma Business Overview

7.10.2 Flynn Pharma Insomnia Medication Quarterly Production and Revenue, 2020

7.10.3 Flynn Pharma Insomnia Medication Product Introduction

7.10.4 Flynn Pharma Response to COVID-19 and Related Developments

7.11 Johnson & Johnson

7.11.1 Johnson & Johnson Business Overview

7.11.2 Johnson & Johnson Insomnia Medication Quarterly Production and Revenue, 2020

7.11.3 Johnson & Johnson Insomnia Medication Product Introduction

7.11.4 Johnson & Johnson Response to COVID-19 and Related Developments

7.12 Meda

7.12.1 Meda Business Overview

7.12.2 Meda Insomnia Medication Quarterly Production and Revenue, 2020

7.12.3 Meda Insomnia Medication Product Introduction

7.12.4 Meda Response to COVID-19 and Related Developments

7.13 Somnus Therapeutics

7.13.1 Somnus Therapeutics Business Overview

7.13.2 Somnus Therapeutics Insomnia Medication Quarterly Production and Revenue, 2020

7.13.3 Somnus Therapeutics Insomnia Medication Product Introduction

7.13.4 Somnus Therapeutics Response to COVID-19 and Related Developments

7.14 Purdue Pharma

7.14.1 Purdue Pharma Business Overview

7.14.2 Purdue Pharma Insomnia Medication Quarterly Production and Revenue, 2020

7.14.3 Purdue Pharma Insomnia Medication Product Introduction

7.14.4 Purdue Pharma Response to COVID-19 and Related Developments

7.15 Neurim

7.15.1 Neurim Business Overview

7.15.2 Neurim Insomnia Medication Quarterly Production and Revenue, 2020

7.15.3 Neurim Insomnia Medication Product Introduction

7.15.4 Neurim Response to COVID-19 and Related Developments

7.16 Minerva Neurosciences

7.16.1 Minerva Neurosciences Business Overview

7.16.2 Minerva Neurosciences Insomnia Medication Quarterly Production and Revenue, 2020

7.16.3 Minerva Neurosciences Insomnia Medication Product Introduction

7.16.4 Minerva Neurosciences Response to COVID-19 and Related Developments

7.17 Pernix Therapeutics

7.17.1 Pernix Therapeutics Business Overview

7.17.2 Pernix Therapeutics Insomnia Medication Quarterly Production and Revenue, 2020

7.17.3 Pernix Therapeutics Insomnia Medication Product Introduction

7.17.4 Pernix Therapeutics Response to COVID-19 and Related Developments

7.18 SkyePharma

7.18.1 SkyePharma Business Overview

7.18.2 SkyePharma Insomnia Medication Quarterly Production and Revenue, 2020

7.18.3 SkyePharma Insomnia Medication Product Introduction

7.18.4 SkyePharma Response to COVID-19 and Related Developments

7.19 Paratek Pharmaceuticals

7.19.1 Paratek Pharmaceuticals Business Overview

7.19.2 Paratek Pharmaceuticals Insomnia Medication Quarterly Production and Revenue, 2020

7.19.3 Paratek Pharmaceuticals Insomnia Medication Product Introduction

7.19.4 Paratek Pharmaceuticals Response to COVID-19 and Related Developments

8 Supply Chain and Sales Channels Analysis

8.1 Insomnia Medication Supply Chain Analysis

8.1.1 Insomnia Medication Supply Chain Analysis

8.1.2 Covid-19 Impact on Insomnia Medication Supply Chain

8.2 Distribution Channels Analysis

8.2.1 Insomnia Medication Distribution Channels

8.2.2 Covid-19 Impact on Insomnia Medication Distribution Channels

8.2.3 Insomnia Medication Distributors

8.3 Insomnia Medication Customers

9 Key Findings

10 Appendix

10.1 About Us

10.2 Disclaimer

Table 1. Overview of the World Economic Outlook Projections

Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)

Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 7. Covid-19 Impact: Global Major Government Policy

Table 8. The Covid-19 Impact on Insomnia Medication Assessment

Table 9. COVID-19 Impact: Insomnia Medication Market Trends

Table 10. COVID-19 Impact Global Insomnia Medication Market Size

Table 11. Global Insomnia Medication Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K Pcs)

Table 12. Global Insomnia Medication Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/Pcs)

Table 13. Global Insomnia Medication Quarterly Market Size, 2020 (US$ Million) & (K Pcs)

Table 14. Global Insomnia Medication Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)

Table 15. Global Insomnia Medication Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K Pcs)

Table 16. Global Insomnia Medication Market Growth Drivers

Table 17. Global Insomnia Medication Market Restraints

Table 18. Global Insomnia Medication Market Opportunities

Table 19. Global Insomnia Medication Market Challenges

Table 20. Key Manufacturers Insomnia Medication Quarterly Revenue, 2019 VS 2020 (US$ Million)

Table 21. Top Manufacturers, Insomnia Medication Market Size, 2019 (K Pcs) & (US$ Million)

Table 22. Insomnia Medication Factory Price by Manufacturers 2020 (USD/Pcs)

Table 23. Location of Key Manufacturers Insomnia Medication Manufacturing Plants

Table 24. Key Manufacturers Insomnia Medication Market Served

Table 25. Date of Key Manufacturers Enter into Insomnia Medication Market

Table 26. Key Manufacturers Insomnia Medication Product Type

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Insomnia Medication Market Size by Type, 2020, (US$ Million)

Table 29. Global Insomnia Medication Market Size by Type, 2020 (K Pcs)

Table 30. Global Insomnia Medication Price: by Type, 2020-2021 (USD/Pcs)

Table 31. Global Insomnia Medication Market Size by Application: 2020-2021 (US$ Million)

Table 32. Global Insomnia Medication Market Size by Application, 2020-2021 (K Pcs)

Table 33. Global Insomnia Medication Price: by Application, 2020-2021 (USD/Pcs)

Table 34. Global Insomnia Medication Market Size by Region, 2019-2021 (US$ Million)

Table 35. Global Insomnia Medication Market Size by Region, 2019-2021 (K Pcs)

Table 36. By Country, North America Insomnia Medication Market Size, 2019-2021 (US$ Million)

Table 37. By Country, North America Insomnia Medication Market Size, 2019-2021 (K Pcs)

Table 38. US Insomnia Medication Market Size, 2019-2021 (US$ Million) & (K Pcs)

Table 39. Canada Insomnia Medication Market Size, 2019-2021 (US$ Million) & (K Pcs)

Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)

Table 41. By Country, Europe Insomnia Medication Market Size, 2019-2021 (US$ Million)

Table 42. By Country, Europe Insomnia Medication Market Size, 2019-2021 (K Pcs)

Table 43. Germany Insomnia Medication Market Size, 2019-2021 (US$ Million) & (K Pcs)

Table 44. France Insomnia Medication Market Size, 2019-2021 (US$ Million) & (K Pcs)

Table 45. UK Insomnia Medication Market Size, 2019-2021 (US$ Million) & (K Pcs)

Table 46. Italy Insomnia Medication Market Size, 2019-2021 (US$ Million) & (K Pcs)

Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)

Table 48. By Region, Asia-Pacific Insomnia Medication Market Size, 2019-2021 (US$ Million)

Table 49. By Region, Asia-Pacific Insomnia Medication Market Size, 2019-2021 (K Pcs)

Table 50. China Insomnia Medication Market Size, 2019-2021 (US$ Million) & (K Pcs)

Table 51. Japan Insomnia Medication Market Size, 2019-2021 (US$ Million) & (K Pcs)

Table 52. South Korea Insomnia Medication Market Size, 2019-2021 (US$ Million) & (K Pcs)

Table 53. India Insomnia Medication Market Size, 2019-2021 (US$ Million) & (K Pcs)

Table 54. ASEAN Insomnia Medication Market Size, 2019-2021 (US$ Million) & (K Pcs)

Table 55. Latin America Insomnia Medication Market Size, 2019-2021 (US$ Million) & (K Pcs)

Table 56. Middle East and Africa Insomnia Medication Market Size, 2019-2021 (US$ Million) & (K Pcs)

Table 57. Eisai Business Overview

Table 58. Eisai Insomnia Medication Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 59. Eisai Insomnia Medication Product

Table 60. Eisai Response to COVID-19 and Related Developments

Table 61. Merck Business Overview

Table 62. Merck Insomnia Medication Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 63. Merck Insomnia Medication Product

Table 64. Merck Response to COVID-19 and Related Developments

Table 65. Pfizer Business Overview

Table 66. Pfizer Insomnia Medication Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 67. Pfizer Insomnia Medication Product

Table 68. Pfizer Response to COVID-19 and Related Developments

Table 69. Sanofi Business Overview

Table 70. Sanofi Insomnia Medication Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 71. Sanofi Insomnia Medication Product

Table 72. Sanofi Response to COVID-19 and Related Developments

Table 73. Takeda Business Overview

Table 74. Takeda Insomnia Medication Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 75. Takeda Insomnia Medication Product

Table 76. Takeda Response to COVID-19 and Related Developments

Table 77. Vanda Pharmaceuticals Business Overview

Table 78. Vanda Pharmaceuticals Insomnia Medication Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 79. Vanda Pharmaceuticals Insomnia Medication Product

Table 80. Vanda Pharmaceuticals Response to COVID-19 and Related Developments

Table 81. Astellas Business Overview

Table 82. Astellas Insomnia Medication Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 83. Astellas Insomnia Medication Product

Table 84. Astellas Response to COVID-19 and Related Developments

Table 85. Dainippon Sumitomo Business Overview

Table 86. Dainippon Sumitomo Insomnia Medication Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 87. Dainippon Sumitomo Insomnia Medication Product

Table 88. Dainippon Sumitomo Response to COVID-19 and Related Developments

Table 89. ECR Pharmaceuticals (Valeant) Business Overview

Table 90. ECR Pharmaceuticals (Valeant) Insomnia Medication Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 91. ECR Pharmaceuticals (Valeant) Insomnia Medication Product

Table 92. ECR Pharmaceuticals (Valeant) Response to COVID-19 and Related Developments

Table 93. Flynn Pharma Business Overview

Table 94. Flynn Pharma Insomnia Medication Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 95. Flynn Pharma Insomnia Medication Product

Table 96. Flynn Pharma Response to COVID-19 and Related Developments

Table 97. Johnson & Johnson Business Overview

Table 98. Johnson & Johnson Insomnia Medication Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 99. Johnson & Johnson Insomnia Medication Product

Table 100. Johnson & Johnson Response to COVID-19 and Related Developments

Table 101. Meda Business Overview

Table 102. Meda Insomnia Medication Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 103. Meda Insomnia Medication Product

Table 104. Meda Response to COVID-19 and Related Developments

Table 105. Somnus Therapeutics Business Overview

Table 106. Somnus Therapeutics Insomnia Medication Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 107. Somnus Therapeutics Insomnia Medication Product

Table 108. Somnus Therapeutics Response to COVID-19 and Related Developments

Table 109. Purdue Pharma Business Overview

Table 110. Purdue Pharma Insomnia Medication Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 111. Purdue Pharma Insomnia Medication Product

Table 112. Purdue Pharma Response to COVID-19 and Related Developments

Table 113. Neurim Business Overview

Table 114. Neurim Insomnia Medication Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 115. Neurim Insomnia Medication Product

Table 116. Neurim Response to COVID-19 and Related Developments

Table 117. Minerva Neurosciences Business Overview

Table 118. Minerva Neurosciences Insomnia Medication Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 119. Minerva Neurosciences Insomnia Medication Product

Table 120. Minerva Neurosciences Response to COVID-19 and Related Developments

Table 121. Pernix Therapeutics Business Overview

Table 122. Pernix Therapeutics Insomnia Medication Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 123. Pernix Therapeutics Insomnia Medication Product

Table 124. Pernix Therapeutics Response to COVID-19 and Related Developments

Table 125. SkyePharma Business Overview

Table 126. SkyePharma Insomnia Medication Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 127. SkyePharma Insomnia Medication Product

Table 128. SkyePharma Response to COVID-19 and Related Developments

Table 129. Paratek Pharmaceuticals Business Overview

Table 130. Paratek Pharmaceuticals Insomnia Medication Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 131. Paratek Pharmaceuticals Insomnia Medication Product

Table 132. Paratek Pharmaceuticals Response to COVID-19 and Related Developments

Table 133. Insomnia Medication Distributors List

Table 134. Insomnia Medication Customers List

Table 135. Covid-19 Impact on Insomnia Medication Customers

List of Figures

Figure 1. Insomnia Medication Product Picture

Figure 2. Insomnia Medication Market Segmentation

Figure 3. Research Objectives

Figure 4. Research Process

Figure 5. Data Triangulation

Figure 6. Research Approach

Figure 7. Commodity Prices-Metals Price Indices

Figure 8. Commodity Prices- Precious Metal Price Indices

Figure 9. Commodity Prices- Agricultural Raw Material Price Indices

Figure 10. Commodity Prices- Food and Beverage Price Indices

Figure 11. Commodity Prices- Fertilizer Price Indices

Figure 12. Commodity Prices- Energy Price Indices

Figure 13. G20+: Economic Policy Responses to COVID-19

Figure 14. Global Insomnia Medication Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)

Figure 15. Global Insomnia Medication Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)

Figure 16. Global Insomnia Medication Market Size, Quarterly Growth, 2020-2021 (%)

Figure 17. Global Insomnia Medication Market Size, Market Share by Type, 2019 VS 2020 (%)

Figure 18. Global Insomnia Medication Market Size, Market Share by Application, 2019 VS 2020 (%)

Figure 19. Global Insomnia Medication Market Size Market Share by Region, 2019 VS 2020 (%)

Figure 20. United States Composite PMI and GDP

Figure 21. Eurozone Composite PMI and GDP

Figure 22. Eurozone Core v. Periphery PMI Output Indices

Figure 23. Core v. Periphery PMI Employment Indices

Figure 24. UK Composite PMI and GDP

Figure 25. Caixin China Composite Output Index

Figure 26. Caixin China General Services Business Activity Index

Figure 27. Japan Composite Output Index

Figure 28. South Korea Manufacturing PMI

Figure 29. India Composite Output Index

Figure 30. ASEAN Manufacturing PMI

Figure 31. By Region, Asia-Pacific Insomnia Medication Market Size Market Share, 2019-2021